National law firm Armstrong Teasdale announces the addition of Counsel Scott A. Williams to its Intellectual Property practice group. With an extensive background in the pharmaceutical industry, he guides emerging and mature businesses in the development and application of chemical and life sciences technologies, working to maximize protection of high-value projects and provide practical, cost-effective solutions to both routine and complex issues.

Williams has deep experience developing and managing global patent portfolios, including the preparation and prosecution of both U.S. and foreign patent applications, and counseling clients on matters such as strategic patent portfolio development, product life cycle planning, Hatch-Waxman patent strategies, and product licensing. He leverages this experience to provide patent portfolio evaluations and other due diligence assessments for clients on licensing and other transactional matters.

Within the pharmaceutical field, Williams has a broad range of experience supporting pharmaceutical preclinical research, clinical candidate development, and product commercialization activities involving small molecules and biologics.  Examples of pharmaceutical products that he previously supported as in-house patent counsel include CALQUENCE®, BRILINTA®, and WAINUA®.